e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Growth factors and fibrogenesis: are they good, bad or both?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Involvement of the Hedgehog signalling pathway in idiopathic pulmonary fibrosis
N. Cigna, E. Farrokhi Moshai, M. S. Joëlle, L. Stervinou-Wémeau, D. Monique, P. Soler, B. Crestani, A. Mailleux (Paris, France)
Source:
Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Session:
Growth factors and fibrogenesis: are they good, bad or both?
Session type:
Oral Presentation
Number:
3233
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Cigna, E. Farrokhi Moshai, M. S. Joëlle, L. Stervinou-Wémeau, D. Monique, P. Soler, B. Crestani, A. Mailleux (Paris, France). Involvement of the Hedgehog signalling pathway in idiopathic pulmonary fibrosis. Eur Respir J 2011; 38: Suppl. 55, 3233
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Increased pulmonary Wnt signaling in patients with sarcoidosis
Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Year: 2007
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019
Year: 2020
Wnt signalling and parenchymal fibrosis
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis
Source: ERS Lung Science Conference 2016
Year: 2016
Dysregulation of the TGF-beta system in idiopathic pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 10s
Year: 2004
LSC Abstract – Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
mTOR signalling is an essential pathway for TGF-β1 induced collagen synthesis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Is TGFb a central mediator in the development of pulmonary fibrosis?
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Defective p53-mediated pro-apoptotic pathway in idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
Hedgehog pathway activation is altered in COPD patients
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Four-and-a-half-LIM-domain (FHL)-2 acts as an enhancer of TGF-beta signaling in pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 296s
Year: 2007
TGF-β and BMP signal transduction pathways in pulmonary hypertension
Source: Annual Congress 2003 - Cell and molecular biology of pulmonary hypertension and COPD
Year: 2003
Involvement of Hedgehog pathway in airway cell differentiation
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Downregulated BMPR2 signaling pathway in nitrofen-induced pulmonary hypoplasia
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
YI02 - Activation of Wnt/beta-catenin signaling promotes lung epithelial repair in emphysema
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept